NEW YORK (GenomeWeb) – Globavir today announced a partnership with BioManguinhos, a division of the Oswaldo Cruz Foundation (Fiocruz), to evaluate the firm's PanGlob RT-PCR Dengue diagnostic assay.

Under the terms of the agreement, the partners will work together to evaluate and develop Globavir's PanGlob for commercial launch in Brazil.

Globavir said that the test is more sensitive in detecting Dengue virus from patient samples than other diagnostic assays and can detect it regardless of the virus' specific serotype.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

What happens to scientific papers when certain journals are no longer published? Some scientists are trying to make sure they don't disappear forever.

A study in Microbiome finds that heavy drinkers have an unhealthy mix of bacteria in their mouths.

Doctors and patients are still trying to figure out what role at-home genetic testing should play in healthcare, Newsweek says.

In Genome Research this week, mismatch repair deficiency in C. elegans, retracing transcriptions start site evolution in the human genome, and more.